© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
July 11, 2021
The federal agency has issued final guidance on how to design studies that include this patient population.
June 28, 2021
Questions remain surrounding the origin of the global pandemic.
June 18, 2021
Here are some news items in the urology field you may have missed this week.
June 17, 2021
Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.
June 16, 2021
Lantheus, the developer of piflufolastat F 18, selected oncology provider GenesisCare to administer the first commercially available dose of the agent.
June 01, 2021
May 27, 2021
The new treatment is a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate.
The FDA has approved the PSMA PET imaging agent 18F-DCFPyL for use in prostate cancer.
May 25, 2021
The Uro-G single-use device arrives at a time when the FDA is actively investigating reports of infections associated with reusable cystoscopes.
May 19, 2021
The device can now be marketed throughout the EU, as well as in Iceland, Liechtenstein, and Norway.